Elsevier BV provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →01Impact factor
Impact factor of Cardiovascular revascularization medicine (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Cardiovascular revascularization medicine published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Cardiac & Cardiovascular Systemrank 131 of 250 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Cardiovascular revascularization medicine
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Cardiovascular revascularization medicine is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Article processing charge listed at about US$3,490.
Is your paper a fit for Cardiovascular revascularization medicine?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
Need a faster review? The fastest journals in Cardiac & Cardiovascular System accept papers in a median of 39 days.
APC waivers and discounts for Cardiovascular revascularization medicine APC about US$3,490
Elsevier: automatic 100% waiver for Research4Life Group A and 50% for Group B in fully open access journals, but only when every author is in an eligible country. Authors in 82 countries get a full waiver.
02Funders
Who funds research published in Cardiovascular revascularization medicine
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
03Indexing
Indexing of Cardiovascular revascularization medicine
- ISSN
- 1553-8389
- eISSN
- 1878-0938
- Publisher
- Elsevier BV all its journals →
- Subjects
- Cardiac & Cardiovascular System
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
04How to submit
How to submit to Cardiovascular revascularization medicine
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Cardiovascular revascularization medicine accepts. Open the official guide for authors and submit from the same page.
- Use the journal's template. Elsevier BV offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Cardiovascular revascularization medicine is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
05Reviewer comments
Reviewer comments and rejection reasons for Cardiovascular revascularization medicine
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Cardiovascular revascularization medicine, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds06Same subject
Cardiac & Cardiovascular System journals with a similar impact factor*
The journals next to Cardiovascular revascularization medicine when the 234 journals of Cardiac & Cardiovascular System in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 127 | Journal of Arrhythmia | 1.49 | ESCI | Fully open access |
| 128 | The Cardiothoracic Surgeon | 1.46 | ESCI | Fully open access |
| 129 | International Journal of Cardiology Congenital Heart Disease | 1.44 | ESCI | Fully open access |
| 130 | International Heart Journal | 1.44 | SCIE | Some open access |
| 132 | Journal of Nuclear Cardiology | 1.43 | SCIE | Subscription |
| 133 | Journal of Cardiac Failure | 1.43 | SCIE | Subscription |
| 134 | Clinical Medicine Insights Cardiology | 1.42 | ESCI | Fully open access |
| 135 | Heart Rhythm O2 | 1.42 | ESCI | Fully open access |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Cardiovascular revascularization medicine right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,109 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
07Questions
Frequently asked questions
What is the impact factor of Cardiovascular revascularization medicine?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Cardiovascular revascularization medicine is 1.43: papers it published in the two previous years were cited 1.43 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Cardiovascular revascularization medicine?
The h-index of Cardiovascular revascularization medicine is 56 (October 2026): 56 of its papers have each been cited at least 56 times. Its i10-index is 935.
What is the APC of Cardiovascular revascularization medicine?
The listed article processing charge (APC) is about US$3,490 for Cardiovascular revascularization medicine (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
What is the quartile of Cardiovascular revascularization medicine?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Cardiovascular revascularization medicine is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Cardiovascular revascularization medicine indexed in Scopus?
Yes. Cardiovascular revascularization medicine appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Cardiovascular revascularization medicine an SCIE journal?
Cardiovascular revascularization medicine is listed in ESCI of the Web of Science Core Collection, but not in SCIE, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Cardiovascular revascularization medicine in Journal Citation Reports (JCR)?
Yes. Cardiovascular revascularization medicine is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Cardiovascular revascularization medicine offer an APC waiver?
Cardiovascular revascularization medicine follows the policy of Elsevier: automatic 100% waiver for Research4Life Group A and 50% for Group B in fully open access journals, but only when every author is in an eligible country. Rules verified 27 October 2026; confirm on the publisher's page.
Who funds research published in Cardiovascular revascularization medicine?
14% of 200 recent research articles in Cardiovascular revascularization medicine name a funder; the funders named most often are Medtronic, University of Galway, Boston Scientific Corporation.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Construction and Building Materials
- Investigative Ophthalmology and Visual Science
- Materials
- European journal of cancer
- Applied Optics
- Transplantation
- IEEE Transactions on Magnetics
- Journal of Physical Chemistry A
- Applied Physics Letters
- Alzheimer's and Dementia
- Neurology
- Frontiers in Immunology
- Journal of Agricultural and Food Chemistry
- Cancer Research
Browse all journals: indexing, impact factor and reviewer comments →